Drugs / CEP-37251
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01159873 | Jul → Oct 2010 | disease of bone structure, osteoporosis | Cephalon | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CEP-37251 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01159873 ↗ |
| Route | Subcutaneous | “subcutaneous (sc) doses” NCT01159873 ↗ |